Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry.

Saved in:
Bibliographic Details
Title: Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry.
Authors: Arman BY; Department of Biochemistry, University of Oxford, OX1 3QU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, OX1 3QU, Oxford, UK., Clarke R; Department of Chemistry, University of Oxford, OX1 3TA, Oxford, UK., Bharucha T; Department of Biochemistry, University of Oxford, OX1 3QU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, OX1 3QU, Oxford, UK., Fernandez LG; Department of Biochemistry, University of Oxford, OX1 3QU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, OX1 3QU, Oxford, UK., Walsby-Tickle J; Department of Chemistry, University of Oxford, OX1 3TA, Oxford, UK., Deats M; Medicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.; Infectious Diseases Data Observatory, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK., Mosca S; Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UKRI, Harwell Campus, Oxford, OX11 0QX, UK., Lin Q; Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UKRI, Harwell Campus, Oxford, OX11 0QX, UK.; Hybrid Materials for Opto-Electronics Group, Department of Molecules and Materials, MESA+ Institute for Nanotechnology, Molecules Center and Center for Brain-Inspired Nano Systems, Faculty of Science and Technology, University of Twente, 7500AE, Enschede, the Netherlands., Banerjee S; Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UKRI, Harwell Campus, Oxford, OX11 0QX, UK., Chunekar SR; Serum Institute of India Pvt. Ltd., 212/2, Hadapsar, Pune, 411028, India., Patil KD; Serum Institute of India Pvt. Ltd., 212/2, Hadapsar, Pune, 411028, India., Gairola S; Serum Institute of India Pvt. Ltd., 212/2, Hadapsar, Pune, 411028, India., Dunachie S; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.; Department of Microbiology and Infectious Diseases, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK.; NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK., Merchant HA; Department of Bioscience, School of Health, Sport and Bioscience, University of East London, Water Lane, London, E15 4LZ, UK., Stokes R; Agilent Technologies LDA UK, Becquerel Avenue, Didcot, OX11 0RA, UK., Kuwana R; Regulation and Safety Unit, Regulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization (WHO), Geneva, Switzerland., Maes A; Regulation and Safety Unit, Regulation and Prequalification Department, Access to Medicines and Health Products Division, World Health Organization (WHO), Geneva, Switzerland., Charrier JP; Department of Microbiology Research & Development, bioMérieux, Marcy l'Étoile, France., Probert F; Department of Chemistry, University of Oxford, OX1 3TA, Oxford, UK., Caillet C; Medicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.; Infectious Diseases Data Observatory, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK., Matousek P; Medicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK.; Central Laser Facility, Research Complex at Harwell, STFC Rutherford Appleton Laboratory, UKRI, Harwell Campus, Oxford, OX11 0QX, UK., McCullagh J; Department of Chemistry, University of Oxford, OX1 3TA, Oxford, UK., Newton PN; Medicine Quality Research Group, NDM Centre for Global Health Research, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK. paul.newton@ndm.ox.ac.uk.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand. paul.newton@ndm.ox.ac.uk.; Infectious Diseases Data Observatory, Centre of Tropical Medicine & Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, OX3 7LG, UK. paul.newton@ndm.ox.ac.uk., Zitzmann N; Department of Biochemistry, University of Oxford, OX1 3QU, Oxford, UK.; Kavli Institute for Nanoscience Discovery, University of Oxford, OX1 3QU, Oxford, UK., Gangadharan B; Department of Biochemistry, University of Oxford, OX1 3QU, Oxford, UK. bevin.gangadharan@bioch.ox.ac.uk.; Kavli Institute for Nanoscience Discovery, University of Oxford, OX1 3QU, Oxford, UK. bevin.gangadharan@bioch.ox.ac.uk.
Source: NPJ vaccines [NPJ Vaccines] 2025 Jan 30; Vol. 10 (1), pp. 19. Date of Electronic Publication: 2025 Jan 30.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-0105
DOI:10.1038/s41541-024-01051-3